Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
CritiTech Particle Engineering Solutions logo — Multi-Service Pharmaceutical Contract Development Manufactur...

CritiTech Particle Engineering Solutions

Multi-Service Pharmaceutical Contract Development Manufacturing Organization (CDMO)

Founded 2001 United States Lawrence, United States 20 employees Series Unknown Total: $13.21M Biotechnology, Pharmaceutical

General Information

Company Name CritiTech Particle Engineering Solutions
Founded Year 2001
Location United States Lawrence, United States +1
Employees 20
Industries Biotechnology, Pharmaceutical
Funding Stage Series Unknown
Social

Get notified when CritiTech Particle Engineering Solutions moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About CritiTech Particle Engineering Solutions

**CritiTech Particle Engineering Solutions** is a rapidly-growing, multi-service pharmaceutical Contract Development Manufacturing Organization (CDMO) and Contract Research Organization (CRO) with extensive experience and expertise in particle engineering, material characterization, analytical testing, early-stage drug development, and pre-clinical and clinical manufacturing. Founded in **2001** and headquartered in the **United States**, the company provides a suite of CDMO services, helping its customers develop new drugs and improved next generation particles from proof-of-concept through Phase III cGMP clinical production. CritiTech Particle Engineering Solutions uses two primary technologies - *Spray Drying* and *Supercritical Precipitation* - to help its customers engineer, formulate and manufacture their drugs. The latest investment of **$7.50M** was made in a **Venture Round** on **01 April 2019** and the investor involved was **Accelerate Venture Partners**. The company operates in the **Biotechnology** and **Pharmaceutical** industries.

Taxonomy: Pharmaceutical CDMO, Contract Development Manufacturing Organization, Particle Engineering, Material Characterization, Analytical Testing, Drug Development, Pre-clinical Manufacturing, Clinical Manufacturing, Spray Drying, Supercritical Precipitation, CRO, Phase III cGMP, Proof-of-Concept, Pharmaceutical Services, Drug Formulation

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 1
Investor
01 Apr 2019
Debt Financing •••••• - 18 Jan 2013
Debt Financing •••••• - 02 Apr 2012
Angel Round •••••• - 31 Dec 2010
Venture Round •••••• - 10 Dec 2009

CritiTech Particle Engineering Solutions Alternatives & Competitors

CritiTech Particle Engineering Solutions vs
Genopis
Genopis

Plasmid DNA-Based Expertise to Propel Your Clinical and Commercial Success with Premier CDMO Service...

Series Unknown
Biotechnology
CritiTech Particle Engineering Solutions vs
Noble Pharma LLC
Noble Pharma LLC United States

A Turnkey Pharmaceutical CDMO

Private Equity
21 employees
Health Care, Manufacturing
CritiTech Particle Engineering Solutions vs
Afton Scientific, LLC
Afton Scientific, LLC United States

Capabilities include small batch aseptic filling for clinical and commercial drug products.

59 employees

FAQ About CritiTech Particle Engineering Solutions

Multi-Service Pharmaceutical Contract Development Manufacturing Organization (CDMO)
CritiTech Particle Engineering Solutions was founded in 2001.
CritiTech Particle Engineering Solutions is headquartered in Lawrence, United States.
CritiTech Particle Engineering Solutions operates in the following industries: Biotechnology, Pharmaceutical.
CritiTech Particle Engineering Solutions has approximately 20 employees.
CritiTech Particle Engineering Solutions has completed 5 funding rounds, raising a total of $13.21M. The latest funding stage is Series Unknown.
Top alternatives and competitors to CritiTech Particle Engineering Solutions include Genopis, Noble Pharma LLC, Afton Scientific, LLC, Chime Biologics, August Bioservices, LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CritiTech Particle Engineering Solutions and Genopis are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors CritiTech Particle Engineering Solutions and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy